•  
  •  
  •  
  •  

2026-08-08 18:04:40

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Deepening Our Presence in Punjab - Strengthening the Tricity Cluster
  • Mini Diamonds India Reports Strong Q1 FY27 Performance: Consolidated Net Profit Up 49.8% YoY to ₹2.67 Crore; Revenue Nearly Doubles to ₹196.53 Crore
  • Kinetic Engineering Reports Q1 FY27 Results: Net Loss at ₹12.96 Crore Amid Higher Material Costs and Inventory Movements
  • Blue Jet Healthcare Reports Q1 FY27 Results: Net Profit Reaches ₹78.26 Crore; Revenue Up 24.9% QoQ
  • One Mobikwik Systems Turns Profitable in Q1 FY27: Reports Net Profit of ₹7.62 Crore; EBITDA Reaches ₹15.78 Crore

Keywords Selected:  License

Stock Report

  • Schaeffler India Becomes First Company to Secure BIS License for Cylindrical Roller Bearings Under New Indian Standard
  • Jindal Saw Ltd updates on API License
  • Nibe Defence and Aerospace Ltd receives license for Firearms manufacturing from DPIIT
  • MobiKwik Secures RBI Approval for Offline PA license
  • Apollo Micro Systems Secures Lifetime Arms Manufacture License from Government of India
  • AGI Infra Ltd receives License from JDA for Group Housing Project
  • Lupin signs License and Supply Agreement with Spektus to Commercialize Novel Antidepressant DeslaFlex™ in Canada
  • Hester receives manufacturing license for Inactivated Avian Influenza Vaccine for poultry
  • Coal India Ltd granted Composite License by Ministry of Mines, Government of India
  • SJS Enterprises announces signing of Technology License cum Supply Agreement with BOE Varitronix Ltd
  • SJS Enterprises Ltd inks agreement with BOE Varitronix Ltd
  • Glenmark Secures Exclusive Multi-Regional Rights to Aumolertinib, an MHRA and NMPA approved Third-Generation EGFR-TKI, from Hansoh Pharma
  • Glenmark Secures Exclusive Multi-Regional Rights to Aumolertinib, an MHRA and NMPA approved Third-Generation EGFR-TKI, from Hansoh Pharma
  • Biocon Biologics Signs Settlement and License Agreement to Commercialize Biosimilar Aflibercept Worldwide
  • JD Cables Ltd granted Electrical Contractor License by Government of West Bengal
  • Associated Alcohols & Breweries Ltd commences manufacturing of Malt Spirits
  • Goodluck India Ltd's Subsidiary Secures Landmark License for Artillery Shells Manufacturing
  • Biocon Biologics Secures U.S. Market Entry Date for Bosaya™ and Aukelso™, Denosumab Biosimilars
  • RCCPL Pvt Ltd declared preferred bidder for KanpaJunapani Limestone Block
  • Nibe Ltd enters into technical collaboration agreement with Elbit Systems Land Ltd
  • Lupin and Zentiva Sign License and Supply Agreement for Commercializing Certolizumab
  • Lupin Ltd enters into agreement with Zentiva for biosimilar Certolizumab Pegol
  • DCX Systems Ltd granted industrial license
  • Sharda Motor Industries Ltd receives Factory License for new plant

Industry News

  • Mygate partners with ACKO to deliver Smarter Insurance at Exclusive Prices to 4mn Households
  • Education Financing startup Propelld gets NBFC license from RBI
  • NTT DATA Payment Services accorded approval by RBI for payment aggregator license

Latest Post

  • Deepening Our Presence in Punjab - Strengthening the Tricity Cluster
  • Mini Diamonds India Reports Strong Q1 FY27 Performance: Consolidated Net Profit Up 49.8% YoY to ₹2.67 Crore; Revenue Nearly Doubles to ₹196.53 Crore
  • Kinetic Engineering Reports Q1 FY27 Results: Net Loss at ₹12.96 Crore Amid Higher Material Costs and Inventory Movements
  • Blue Jet Healthcare Reports Q1 FY27 Results: Net Profit Reaches ₹78.26 Crore; Revenue Up 24.9% QoQ
  • One Mobikwik Systems Turns Profitable in Q1 FY27: Reports Net Profit of ₹7.62 Crore; EBITDA Reaches ₹15.78 Crore


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025